£99.56

Springer 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£100 today · usual range £59–£102 · best ever £59

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days · 91 data points

Historical
Generating forecast…
£101.99 £55.18 £65.40 £75.61 £85.82 £96.03 £106.25 14 April 2026 06 May 2026 29 May 2026 20 June 2026 13 July 2026

Price Distribution

Price distribution over 91 days • 7 price levels

Days at Price
Current Price
28 days 1 day 5 days 14 days 22 days · current 9 days 12 days 0 7 14 21 28 £59 £66 £86 £99 £100 £101 £102 Days at Price

Price Analysis

Most common price: £59 (28 days, 30.8%)

Price range: £59 - £102

Price levels: 7 different prices over 91 days

Description

This unique book provides a retrospective analysis of the changes in survival outcomes at the University of Texas, M.D. Anderson Cancer Center over the past six decades. Since opening its doors in 1944, M.D. Anderson has kept a continuous, uninterrupted data repository of the treatment and outcomes of each of its patients. It is this visionary database from the center’s tumor registry which makes this groundbreaking book possible. Tracking results across time, this book shows radical shifts in outcomes trends, where great progress has been made, and where there is still a long way to go, and offers a snapshot into the parallel history of developments in care. Such data is crucial to informing how patients are counseled, how treatment decisions are determined, and how prognoses are made. 60 Years of Survival Outcomes at the University of Texas, M.D. Anderson Cancer Center is the only book to concurrently present longitudinal data on survival outcomes across the spectrum of rare and common cancers. Each chapter deals with a specific disease site, discussing current management approaches and presenting key data replete with illustrative charts, graphs, and tables. With the resources available only to the practitioners at this inimitable institution, this book heralds a cornerstone moment in the study of survival outcomes and the depth of our knowledge of cancer care. From the Back Cover This unique book provides a retrospective analysis of the changes in survival outcomes at The University of Texas M.D. Anderson Cancer Center over the past six decades. Since opening its doors in 1944, M.D. Anderson has kept a continuous, uninterrupted data repository of the treatment and outcomes of each of its patients. It is this visionary database from the Center’s tumor registry which makes this groundbreaking book possible. Tracking results across time, the book shows radical shifts in outcomes trends, where great progress has been made, and where there is still a long way to go, and offers a snapshot of the parallel history of developments in care. Such data is crucial to informing how patients are counseled, how treatment decisions are determined, and how prognoses are made. 60 Years of Survival Outcomes at The University of Texas M.D. Anderson Cancer Center is the only book to concurrently present longitudinal data on survival outcomes across the spectrum of rare and common cancers. Each chapter deals with a specific disease site, discussing current management approaches and presenting key data replete with illustrative charts, graphs, and tables. With the resources available only to the practitioners at this inimitable institution, this book heralds a cornerstone moment in the study of survival outcomes and the depth of our knowledge of cancer care.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
22 November 2012
Listed Since
27 July 2012

Barcode

No barcode data available

Similar Products You Might Like

60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center
93% match

60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center

Springer

£80.64 06 Jun 2026
Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)
84% match

Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)

Springer

£66.52 17 May 2026
The MASCC Textbook of Cancer Supportive Care and Survivorship
80% match

The MASCC Textbook of Cancer Supportive Care and Survivorship

Springer

£111.72 05 Jun 2026
Survivorship Care for Cancer Patients: A Clinician’s Handbook
80% match

Survivorship Care for Cancer Patients: A Clinician’s Handbook

Springer

£103.70 05 Jun 2026
Pancreatic Cancer (MD Anderson Solid Tumor Oncology Series)
79% match

Pancreatic Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£166.99 09 Jun 2026
Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)
79% match

Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)

Springer

£88.17 05 Jun 2026
Uterine Cancer: Screening, Diagnosis, and Treatment (Current Clinical Oncology)
79% match

Uterine Cancer: Screening, Diagnosis, and Treatment (Current Clinical Oncology)

Springer

£80.64 08 Jun 2026
Breast Cancer (MD Anderson Solid Tumor Oncology Series)
79% match

Breast Cancer (MD Anderson Solid Tumor Oncology Series)

Springer

£78.01 06 Jul 2026
Health Services for Cancer Survivors: Practice, Policy and Research
79% match

Health Services for Cancer Survivors: Practice, Policy and Research

Springer

£107.98 24 May 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
79% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£104.00 14 Jun 2026
Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)
79% match

Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)

Springer

£102.71 12 Jun 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
78% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 17 May 2026
Bone Sarcoma (MD Anderson Cancer Care Series)
78% match

Bone Sarcoma (MD Anderson Cancer Care Series)

Springer

£73.10 26 May 2026
Patient Surveillance After Cancer Treatment (Current Clinical Oncology)
78% match

Patient Surveillance After Cancer Treatment (Current Clinical Oncology)

Humana

£141.51 13 Jun 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
78% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 26 May 2026
Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)
78% match

Genitourinary Cancer 1: 6 (Cancer Treatment and Research, 6)

Springer

£85.30 05 Jun 2026
Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)
77% match

Biostatistical Applications in Cancer Research: 113 (Cancer Treatment and Research, 113)

Springer

£141.52 02 Jun 2026
Perioperative Inflammation as Triggering Origin of Metastasis Development
77% match

Perioperative Inflammation as Triggering Origin of Metastasis Development

Springer

£110.42 15 Jun 2026
Oncologic Therapies
77% match

Oncologic Therapies

Springer

£81.58 25 May 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
77% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 11 Jun 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
77% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
77% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
77% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 31 May 2026
Current Cancer Therapeutics
77% match

Current Cancer Therapeutics

Springer

£72.12 12 Jul 2026